BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs2230926
,
PRKCA
,
Fatty acid metabolic process
,
Obesity
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myd88 protein human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Peritoneal macrophage gene expression in MyD88 knockout mice after treatment with ApoA-I
Epidermal keratinocytes treated with IL1B, IL36A, IL36B or IL36G
Leukemia monocytic THP-1 cells treated with SARS-CoV-2 spike protein
Synoviocytes of rheumatoid arthritis patients treated with IL17A or IL17F
Explore Curated Studies Results
Literature
Most Relevant Literature
Expression of MYD88 L265P Mutation in Subtypes of Diffuse Large B-Cell Lymphoma in the Pakistani Pop…
Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macrogl…
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 …
Isolated primary vitreoretinal lymphoma (case report)].
Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central N…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B A…
Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation
RNA Cloning and Visualization in Human Atherosclerosis
Ibrutinib + Venetoclax in Untreated WM
A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ